NCH2.DENCH2.DEXETRA
Loading
EBITDA Margin Over TimeContracting
Percentile Rank40
3Y CAGR+1.4%
5Y CAGR-19.5%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+1.4%/yr
Annual compound
5Y CAGR
-19.5%/yr
Recent acceleration
Percentile
P40
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
20254.14%+78.5%
20242.32%-64.3%
20236.50%+63.4%
20223.97%-58.4%
20219.56%-22.1%
202012.28%-